These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 29338572)
21. Factors Affecting Number of Diabetes Management Activities Provided by Pharmacists. Lo A; Lorenz K; Cor K; Simpson SH Can J Diabetes; 2016 Dec; 40(6):535-542. PubMed ID: 27373434 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. Lounsbery JL; Green CG; Bennett MS; Pedersen CA J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597 [TBL] [Abstract][Full Text] [Related]
23. Description of the characteristics of pharmacist-based immunization services in North Carolina: results of a pharmacist survey. Kummer GL; Foushee LL J Am Pharm Assoc (2003); 2008; 48(6):744-51. PubMed ID: 19019803 [TBL] [Abstract][Full Text] [Related]
24. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. Rodriguez MI; McConnell KJ; Swartz J; Edelman AB J Am Pharm Assoc (2003); 2016; 56(5):521-6. PubMed ID: 27594105 [TBL] [Abstract][Full Text] [Related]
25. Pharmacists' experience with prescribing hormonal contraception in Oregon. Rodriguez MI; Biel FM; Swartz JJ; Anderson L; Edelman AB J Am Pharm Assoc (2003); 2018; 58(6):608-613. PubMed ID: 30190201 [TBL] [Abstract][Full Text] [Related]
26. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy. Nusair MB; Guirguis LM Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265 [TBL] [Abstract][Full Text] [Related]
27. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California. Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570 [TBL] [Abstract][Full Text] [Related]
28. Pharmacists' roles in oncology pharmacy services: Results of a global survey. Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267 [TBL] [Abstract][Full Text] [Related]
29. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Bourne RS; Whiting P; Brown LS; Borthwick M Int J Pharm Pract; 2016 Apr; 24(2):104-13. PubMed ID: 26420309 [TBL] [Abstract][Full Text] [Related]
30. The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study. Alsabbagh MW; Houle SKD; Waite NM Res Social Adm Pharm; 2020 Jan; 16(1):84-89. PubMed ID: 31000334 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit. Crespo A; Tyszka M J Oncol Pharm Pract; 2017 Jun; 23(4):243-248. PubMed ID: 26911478 [TBL] [Abstract][Full Text] [Related]
32. Direct patient care services by community and ambulatory care pharmacists in Idaho. Nguyen E; Holmes JT; Narsinghani R; O'Connor S; Fuit MW; Thaden L; Robinson R Int J Clin Pharm; 2020 Dec; 42(6):1480-1489. PubMed ID: 32860182 [TBL] [Abstract][Full Text] [Related]
33. Positioning pharmacists' roles in primary health care: a discourse analysis of the compensation plan in Alberta, Canada. Hughes CA; Breault RR; Hicks D; Schindel TJ BMC Health Serv Res; 2017 Nov; 17(1):770. PubMed ID: 29169360 [TBL] [Abstract][Full Text] [Related]
34. Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing. Stewart DC; George J; Diack HL; Bond CM; McCaig DJ; Cunningham IS; Munro K; Pfleger D Ann Pharmacother; 2009 Jun; 43(6):1115-21. PubMed ID: 19417108 [TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements. Penm J; Chaar B; Moles R Int J Clin Pharm; 2015 Jun; 37(3):485-96. PubMed ID: 25733064 [TBL] [Abstract][Full Text] [Related]
36. Perceptions of Saskatchewan community pharmacists regarding a prior-authorization program. Perepelkin J; Dobson RT J Manag Care Pharm; 2007 Sep; 13(7):589-97. PubMed ID: 17874865 [TBL] [Abstract][Full Text] [Related]
37. Improving medication safety for home nursing clients: A prospective observational study of a novel clinical pharmacy service-The Visiting Pharmacist (ViP) study. Lee CY; Beanland C; Goeman D; Petrie N; Petrie B; Vise F; Gray J; Elliott RA J Clin Pharm Ther; 2018 Dec; 43(6):813-821. PubMed ID: 29770474 [TBL] [Abstract][Full Text] [Related]
38. Medication reconciliation by clinical pharmacists in an outpatient family medicine clinic. Milone AS; Philbrick AM; Harris IM; Fallert CJ J Am Pharm Assoc (2003); 2014; 54(2):181-7. PubMed ID: 24531920 [TBL] [Abstract][Full Text] [Related]
39. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents. Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528 [TBL] [Abstract][Full Text] [Related]
40. Advancing pharmacist prescribing privileges: Is it time? Majercak KR J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]